Remetinostat, also known as SHP-141, is a topical formulation containing the histone deacetylase (HDAC) inhibitor with potential antineoplastic activity.
For research use only. We do not sell to patients.
| Name | Remetinostat |
|---|---|
| Iupac Chemical Name | methyl 4-((8-(hydroxyamino)-8-oxooctanoyl)oxy)benzoate |
| Synonyms | Remetinostat; SHP-141; SHP-141; SHP-141; SHAPE |
| Molecular Formula | C16H21NO6 |
| Molecular Weight | 323.345 |
| Smile | O=C(OC)C1=CC=C(OC(CCCCCCC(NO)=O)=O)C=C1 |
| InChiKey | XDZAHHULFQIBFE-UHFFFAOYSA-N |
| InChi | InChI=1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18) |
| CAS Number | 946150-57-8 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |